Home > News > AMAG Anemia Drug Eyes Growing Market
March 8th, 2010
AMAG Anemia Drug Eyes Growing Market
Abstract:
Most biotech firms bet their future on only one drug. AMAG Pharmaceuticals (AMAG) is no exception.
The company relies heavily on Feraheme, a new IV injection treatment for iron-deficiency anemia in adult patients with chronic kidney disease.
People with chronic kidney diseases often suffer from iron-deficiency anemia. Without enough iron, the body can't produce enough hemoglobin in red blood cells. That makes people tired and pale because of a lack of oxygen in blood cells carried throughout the body.
Feraheme can be injected into a patient in 17 seconds, while conventional IV iron treatment takes 15 to 60 minutes for infusion, AMAG says. Also, Feraheme requires twice-a-week injections while other IV irons need up to 10 treatments a month.
The drug is a product of nanotechnology. It uses tiny nano-particles of iron oxide, which makes quick injection possible. The Food and Drug Administration approved it in June.
Source:
investors.com
Bookmark:
| Related Links |
| Related News Press |
News and information
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Products
Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018
Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018
Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018
Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018
Govt.-Legislation/Regulation/Funding/Policy
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Nanomedicine
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Nanobiotechnology
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||